CY1106311T1 - Χορηγηση απο το στομα παραγωγων ταξοειδων - Google Patents

Χορηγηση απο το στομα παραγωγων ταξοειδων

Info

Publication number
CY1106311T1
CY1106311T1 CY20061100625T CY061100625T CY1106311T1 CY 1106311 T1 CY1106311 T1 CY 1106311T1 CY 20061100625 T CY20061100625 T CY 20061100625T CY 061100625 T CY061100625 T CY 061100625T CY 1106311 T1 CY1106311 T1 CY 1106311T1
Authority
CY
Cyprus
Prior art keywords
oral administration
taxo
species
taxoid
pharmaceutical form
Prior art date
Application number
CY20061100625T
Other languages
English (en)
Inventor
Marie-Christine Bissery
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of CY1106311T1 publication Critical patent/CY1106311T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

Η παρούσα εφεύρεση αφορά στη χρήση νέας φαρμακευτικής μορφής παραγώγων ταξοειδών. Πιο συγκεκριμένα αφορά τη χορήγηση από το στόμα μιας φαρμακευτικής μορφής ταξοειδούς που φέρει δύο ομάδες αλκοξέος στις θέσεις 7 και 10.
CY20061100625T 1999-01-13 2006-05-15 Χορηγηση απο το στομα παραγωγων ταξοειδων CY1106311T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99400072A EP1020188A1 (en) 1999-01-13 1999-01-13 New use of taxoid derivatives
PCT/EP2000/000943 WO2000041482A2 (en) 1999-01-13 2000-01-11 Oral administration of taxoid derivatives
EP00910645A EP1140064B1 (en) 1999-01-13 2000-01-11 Oral administration of taxoid derivatives

Publications (1)

Publication Number Publication Date
CY1106311T1 true CY1106311T1 (el) 2011-10-12

Family

ID=8241854

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20061100625T CY1106311T1 (el) 1999-01-13 2006-05-15 Χορηγηση απο το στομα παραγωγων ταξοειδων

Country Status (9)

Country Link
EP (2) EP1020188A1 (el)
AT (1) ATE317694T1 (el)
AU (1) AU3278400A (el)
CY (1) CY1106311T1 (el)
DE (1) DE60026011T2 (el)
DK (1) DK1140064T3 (el)
ES (1) ES2257286T3 (el)
PT (1) PT1140064E (el)
WO (1) WO2000041482A2 (el)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417491B (zh) * 2011-10-31 2013-11-06 江苏红豆杉生物科技有限公司 以10-去乙酰基-巴卡丁iii为原料制备卡巴他赛的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2129288C (en) * 1993-08-17 2000-05-16 Jerzy Golik Phosphonooxymethyl esters of taxane derivatives
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2745814B1 (fr) * 1996-03-06 1998-04-03 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent
US6346543B1 (en) * 1998-08-17 2002-02-12 Aventis Pharma S.A. Use of a taxoid to treat abnormal cell proliferation in the brain

Also Published As

Publication number Publication date
PT1140064E (pt) 2006-06-30
DE60026011D1 (de) 2006-04-20
WO2000041482A3 (en) 2000-11-02
ATE317694T1 (de) 2006-03-15
EP1020188A1 (en) 2000-07-19
DE60026011T2 (de) 2006-10-26
WO2000041482A2 (en) 2000-07-20
ES2257286T3 (es) 2006-08-01
EP1140064A2 (en) 2001-10-10
AU3278400A (en) 2000-08-01
DK1140064T3 (fr) 2006-06-12
EP1140064B1 (en) 2006-02-15

Similar Documents

Publication Publication Date Title
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
HUP0301320A2 (hu) Glikopeptid-foszfonát-származékok
NO20100302L (no) Sammensetninger som inneholder organiske forbindelser
CY1108522T1 (el) Μεθοδος συνθεσης της περινδοπριλης και των φαρμακευτικως αποδεκτων αλατων της
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
PT977562E (pt) Metodos e composicoes para administracao de taxanos
CO5160286A1 (es) Composiciones farmaceuticas ne orlistat y quitosan
FR2775596B1 (fr) Nouvelles compositions pharmaceutiques
BR9810495A (pt) Composição farmacêutica
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
FR2764889B1 (fr) Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
NO20032788D0 (no) Modafinil-forbindelse og cyklodekstrinblandinger
DE50005529D1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
DK1104289T3 (da) Hidtil ukendte orale formuleringer for 5-HT4-agonister eller -antagonister
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
BR0206960A (pt) Composição farmacêutica oral, e, uso de um polìmero de ftalato de hidroxipropilmetilcelulose
CY1106311T1 (el) Χορηγηση απο το στομα παραγωγων ταξοειδων
CY1106712T1 (el) Υποκατεστημενα παραγωγα 5-αμινο-1-πεντεν-3-ολης
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
RS51081B (sr) Nova sinergistička kombinacija koja uključuje roflumilast i formoterol
FR2779145B1 (fr) Nouvelles compositions pharmaceutiques
HRP20070081T5 (en) Nasal pharmaceutical composition of piribedil
ATE250340T1 (de) 7-methylthiooxomethyl- und 7- methylthiodioxomethyl-paclitaxele